A new study reveals that high blood pressure, not diabetes, is the deadliest risk factor in metabolic dysfunction-associated steatotic liver disease (MASLD). Researchers also identified low HDL cholesterol and diabetes as major threats. Obesity compounds risks, with mortality rising 15% per added factor. Experts urge early detection and management of blood pressure and cholesterol to save lives.